Geomembrane Market Qualitative Analysis By Industry Overview, Trends, Market Drivers And Restraints 2014-2025

Global Geomembrane Market is expected to reach USD 2.43 billion by 2025, according to a new report by Grand View Research, Inc. Increasing spending towards waste and water management programs in Germany, Russia, China, and India is anticipated to drive the market. In addition, positive outlook towards mining industry in Middle East countries, South Africa, Peru, and Chile is expected to play a crucial role in increasing the application of geomembrane as a barrier medium to control industrial waste.

HPDE was the most extensively used raw material accounting for 32.6% of the global geomembrane market volume in 2015. Low cost, ease of installation, good welding strength, excellent low-temperature performance and good thermal stability during exposure makes HDPE as a favourable choice of raw material for the production geomembrane.  

Full Research Report on Global Geomembrane Market Analysis: http://www.grandviewresearch.com/industry-analysis/geomembrane-market

Further key findings from the report suggest:

• The global demand for geomembranes was 809.9 million square meters in 2015 and is expected to witness growth on account of its increasing usage for water management, mining, and civil construction
• EPDM is increasingly used as a raw material for the production of geomembrane on account of providing good flexibility, excellent mechanical strength, and effective UV resistance, and thus, is expected to witness the fastest growth at a CAGR of 6% over the forecast period. Geomembrane manufacturers mix EPDM with carbon black, curing agents and processing chemicals to produce larger sheet sizes which induce properties including excellent elastic elongation and superior weathering resistance.
• The global market for extruded geomembranes was 486.5 million square meters in 2015, making it the most widely utilized technology for manufacturing. Extrusion results in the formation of thin sheets which allows for flexibility of the geomembranes resulting in increasing its durability under stress.
• The robust presence of mining base in Australia and China in light of the abundance of minerals such as steel and diamond, respectively, coupled with improvement in mining sectors of African countries including South Africa and Nigeria in light of regulatory support is expected to result in significant demand for geomembranes. Mining is expected to grow at a CAGR of 4.9%, in terms of volume over the forecast period.
• Asia Pacific was the largest consumer of geomembranes in 2015 accounting for 34.3% of the global volume share, and the trend is expected to continue over the forecast period. Rising awareness towards engineering polymers in the construction industry of emerging economies including China and India in light of new capacity additions by companies including BASF and Dow at the domestic level is expected to new markets over the next seven years.
• Key operating companies in the market include GSE Holdings, AGRU, CETCO, NAUE, and Solmax. Companies are focusing on expanding their market share via numerous strategies including mergers & acquisition and capacity expansions. For instance, in May 2014, GSE Environmental, Inc. opened a new manufacturing facility in Suzhou, China. In February 2014, GSE Holding signed a global distribution agreement with Tenax Group. This agreement will enable GSE Holding to distribute the products of Tenax Group, which include reinforced geosynthetics on a global level.

View Research Insight on Geomembrane Market by Grand View Research: http://www.grandviewresearch.com/research-insights/geomembrane-market-insights-industry-size-trends-market-study

Grand View Research has segmented the Global Geomembrane Market by raw material, technology, application and region:

Raw Material Outlook (Volume, Million Square Meters; Revenue, USD Million, 2014 - 2025)

• HDPE
• LDPE
• EPDM
• PVC
• Others

Technology Outlook (Volume, Million Square Meters; Revenue, USD Million, 2014 - 2025)

• Extrusion
• Calendering
• Others

Application Outlook (Volume, Million Square Meters; Revenue, USD Million, 2014 - 2025)

• Waste Management
• Water Management
• Mining
• Tunnels & Civil Construction
• Others

Regional Outlook (Volume, Million Square Meters; Revenue, USD Million, 2014 - 2025)

North America

• U.S.

Europe

• Germany

Asia Pacific

• China

Latin America

• Brazil

MEA

View Press Release Of this research report by Grand View Research: 

http://www.grandviewresearch.com/press-release/global-geomembrane-market

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com

Genomics Market Is Estimated To Reach USD 22.1 Billion By 2020

Global Genomics Market is estimated to reach USD 22.1 billion by 2020, growing at an expected CAGR of 10.3% from 2014 to 2020. Genomics is a subunit of biology that is concerned with the study of genes and its functions and brings together the function and structure of genomes. Genomics is applied in several fields such as biotechnology, genomic medicine, anthropology, and various other social sciences. It consists of functional genomics, comparative genomics, pharmacogenomics, structural genomics, and epigenomics.

The global genomics market has undergone an increase in its market potential due to technological developments. Adding to it, factors including growing prevalence of fetal disorders such as diabetes and cancer, an increase in partial or full compensation by the government of certain countries add to the market’s growth across the globe.

In 2013, genomics-based diagnostics held the largest share of market revenue at over 35% on account of the occurrence of a considerably larger number of research & development initiatives. However, genomics-based personalized medicine segment is projected to have the highest growth rate, at an anticipated CAGR of over 12%, from 2014 to 2020. The high growth rate of the segment is on account of the growing demand for population-based therapeutic solutions and consequent increase in R&D initiatives.

Full Research Report on Global Genomics Market Analysis:  http://www.grandviewresearch.com/industry-analysis/genomics-market

Consumable led the global genomics market share at over 50% in 2013. This is on account of rising adoption rate of genomic testing for several applications, particularly in the field of drug development and discovery. The consumables segment is also expected to lead the market with the fastest growth rate over the forecast period owing to increasing applications and reduced costs of consumables.

In 2013, PCR technology had the largest market share of over 45% owing to technological developments and involvement of government policies about funding of research & development. 

Nucleic acid extraction and purification technology are expected to witness the highest growth rate, at a projected CAGR of 10.1%, from 2014 to 2020 on account of developing technologies for genome profiling and growing methods for new diagnostics tools and techniques.

North America was the major regional market, generating over 35% of the total revenue of the global genomics market. This was on account of various reasons such as high patient awareness levels, the presence of sophisticated infrastructure of healthcare. Asia Pacific is likely to be the highest growing region, at a projected CAGR of 12.7% over the next six years. The presence of large unmet medical needs and the increasing demand for economical clinical outsourcing in the emerging nations of 

China and India is anticipated to drive the high growth rate.

The major market players include Agilent Technologies, Bio-Rad Laboratories Inc., Illumina Inc., Roche Diagnostics, Cepheid, Affymetrix, Inc., BGI, GE Healthcare, Qiagen, and Life Technologies.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Genomics Market on the basis of product, application, technology and region:

Genomics Product Outlook
            • Instruments
            • Consumables
            • Services
Genomics Application Outlook
            • Diagnostics
            • Personalized Medicines
            • Drug Discovery and Development
            • Academic Research
            • Agriculture
Genomics Technology Outlook
            • PCR
            • DNA Sequencing
            • DNA Microarray
            • Nucleic Acid Extraction and Purification
Genomics Regional Outlook
            • North America
            • Europe
            • Asia Pacific
            • RoW

View Blog On this research report by Grand View Research: http://www.grandviewresearch.com/blog/genomics-market                 

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Genome Editing Market Study Covers Revenue Forecast, Company Share, Competitive Landscape, Growth Factors And Trends 2014-2025

Global Genome Editing Market is anticipated to reach USD 8.1 billion by 2025, according to a new report by Grand View Research, Inc. Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.

The ability of genome editing therapies to offer a significant improvement over current treatment options is important in enabling editing technologies to capture significant revenue share. Improved efficacy, reduced side effects, and the potential for cure for specific diseases, can be attributed to induce growth in the coming years. 

Moreover, technological advancements with respect to the development of novel vectors for delivery is anticipated to fuel growth in the coming years. Rising competition amongst the operating entities in order to gain the larger share of revenue is also responsible for the projected growth. These companies leverage industry collaborations for the acceleration of diversified product pipelines. 

Full Research Report on Global Genome Editing Market Analysis: http://www.grandviewresearch.com/industry-analysis/genome-editing-market

Further Key Findings from the Report Suggest:

• There has been great excitement surrounding the highly adaptable CRISPR technology.
• The increased ease of retargeting and the ability to multiplex goes a long way toward explaining the speed with which CRISPR-centric companies have sprung up.
• Ex-vivo mode of delivery accounted for the largest share of the revenue.
• Therapy through ex-vivo mode of delivery allow the control over the specific dosage of therapeutic molecules delivered to cells.
• Cell line engineering dominated with respect to revenue generation owing to the high utilization of technology in stem cell engineering.
• There is comparatively, higher adoption of the technology in the biotechnology and pharmaceutical organizations for the purpose of therapeutic development.
• Availability of other services such as gRNA library production and screening service along with editing is anticipated to propel growth in the outsourcing services.
• Asia Pacific is anticipated to witness fastest growth over the forecast period owing to rising penetration of technology in comparatively immature market.
• Key players contributing in this market are Thermo Fisher Scientific, Inc., Sangamo, Editas Medicine, Recombinetics, Inc, Sigma Aldrich Corporation, CRISPR THERAPEUTICS, Intellia Therapeutics, Inc., Caribou Biosciences, Inc.
• These participants are capitalizing on unique advantages offered by the nuclease technology, they are working on.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Genome Editing Market on the basis of technology, delivery method, application, end-use, service, and region: 

Molecular Scissors/Genome Editing Technology Outlook (Revenue, USD Million, 2014 - 2025)

• (CRISPR)/Cas9
• TALENs/MegaTALs
• ZFN
• Others

Molecular Scissors/Genome Editing Delivery Method Outlook (Revenue, USD Million, 2014 - 2025)

• Ex-Vivo
• In-Vivo

Molecular Scissors/Genome Editing Application Outlook (Revenue, USD Million, 2014 - 2025)

• Cell Line Engineering
• Animal Genetic Engineering
• Plant Genetic Engineering
• Other Applications

Molecular Scissors/Genome Editing End-use Outlook (Revenue, USD Million, 2014 - 2025)

• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Contract Research Organizations

Molecular Scissors/Genome Editing Service Outlook (Revenue, USD Million, 2014 - 2025)

• Contract
• In-house

Molecular Scissors/Genome Editing Service Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Middle East and Africa (MEA)
• South Africa

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-genome-editing-market                

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Genomics In Cancer Care Market Is Expected To Grow At CAGR Of 17.3% Over The Forecast Period 2012-2022

Global Genomics In Cancer Care Market is expected to reach USD 9.22 billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer coupled with adoption of next generation sequencing for the diagnosis & treatment is expected to fuel the market with future growth opportunities. Increasing incidences of cancer triggers the demand for cost effective and accurate diagnostics in coming years. 

In addition, increasing demand for personalized medicines in molecular characterization of cancer to identify therapeutic targets is the factor attributing towards the market growth. Similarly, factors such as cost reduction in genome sequencing, growing healthcare expenditure levels and development of effective diagnostics & therapeutic procedures for cancer are responsible for the potential growth of genomics in cancer care. 

Full Research Report on Global Genomics In Cancer Care Market Analysis:  http://www.grandviewresearch.com/industry-analysis/genomics-in-cancer-care-market

Further key findings from the study suggest:

• Instrument segment dominated the overall market in terms of revenue share as of 2014 and accounted for 33.4% of market owing to high cost associated with it. Whereas, consumables are most widely used product segment in genome testing as they are indispensible component and frequently required to perform the test.
• Demand for services such as next generation sequencing, PCR and other such as cancer risk management & genetic testing are expected to grow over the forecast period due to increasing outsourcing activities to perform genome analysis. High cost of performing genetic tests and growing awareness pertaining to associated benefits with the use of these technologies are high impact rendering drivers for this segment.
• Drug discovery and development segment is expected to show lucrative CAGR of 17.6% during the forecast period owing to increasing demand for effective treatment for cancer and growing investment in biomedicines by manufacturers for the development of novel products. 
• Genome sequencing held the dominant share of technology segment as it is most prominently used for diagnosis due to associate benefits such as faster and accurate method. It is expected to show significant growth rate of 17.5% in coming years owing to remarkable decrease in the cost for genome sequencing and increasing adoption rates.
• The cancer research segment held the largest share of 34.1% in 2014 due to increasing demand for faster & accurate diagnostic methods to treat variety of cancer. Other use such as commercial adoption of genetic testing is expected to be fastest growing segment owing to increasing demand of cancer genomic testing to fulfill unmet needs in healthcare sector.
• Some key players operating in this market include Beckman Coulter Inc., Illumina, Inc, Affymetrix, Roche Diagnostics, Agilent Technologies, Cancer Genetics Inc., Danaher Corporation, Bio-Rad Labs, Pacific Biosciences, Quest Diagnostics, Sigma Aldrich, Luminex, Thermo Fisher scientific, Oxford Gene Technology., PerkinElmer, Qiagen, and GE Healthcare.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Genomics In Cancer Care Market on the basis of application and region: 

Global genomics in cancer care product outlook (Revenue, USD Million, 2012 - 2022)

• Instruments 
• Consumables
• Services

Global genomics in cancer care application (Revenue, USD Million, 2012 - 2022)

• Diagnostics
• Personalized medicine
• Drug discovery & development
• Research

Global Genomics in cancer care technology  Outlook (Revenue, USD Million, 2012 - 2022)

• Genome sequencing
• PCR
• Microarrays
• Nucleic acid extraction & purification
• Other

Genomics in cancer care regional outlook (Revenue, USD Million, 2012 - 2022)

• North America
• U.S
• Canada
• Europe
• U.K 
• Germany
• Asia Pacific
• Japan
• China
• India
• Latin America
• Mexico
• Brazil
• MEA
•  South Africa

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-genomics-in-cancer-care-market                 

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Genome Editing Market Analysis By Technology, Application, End-Use, Application and Segment Forecast Up To 2025

Global Genome Editing Market is anticipated to reach USD 8.1 billion by 2025, according to a new report by Grand View Research, Inc. Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.

The ability of genome editing therapies to offer a significant improvement over current treatment options is important in enabling editing technologies to capture significant revenue share. Improved efficacy, reduced side effects, and the potential for cure for specific diseases, can be attributed to induce growth in the coming years. 

Moreover, technological advancements with respect to the development of novel vectors for delivery is anticipated to fuel growth in the coming years. Rising competition amongst the operating entities in order to gain the larger share of revenue is also responsible for the projected growth. These companies leverage industry collaborations for the acceleration of diversified product pipelines. 

Full Research Report on Global Genome Editing Market Analysis: http://www.grandviewresearch.com/industry-analysis/genome-editing-market

Further Key Findings from the Report Suggest:

• There has been great excitement surrounding the highly adaptable CRISPR technology.
• The increased ease of retargeting and the ability to multiplex goes a long way toward explaining the speed with which CRISPR-centric companies have sprung up.
• Ex-vivo mode of delivery accounted for the largest share of the revenue.
• Therapy through ex-vivo mode of delivery allow the control over the specific dosage of therapeutic molecules delivered to cells.
• Cell line engineering dominated with respect to revenue generation owing to the high utilization of technology in stem cell engineering.
• There is comparatively, higher adoption of the technology in the biotechnology and pharmaceutical organizations for the purpose of therapeutic development.
• Availability of other services such as gRNA library production and screening service along with editing is anticipated to propel growth in the outsourcing services.
• Asia Pacific is anticipated to witness fastest growth over the forecast period owing to rising penetration of technology in comparatively immature market.
• Key players contributing in this market are Thermo Fisher Scientific, Inc., Sangamo, Editas Medicine, Recombinetics, Inc, Sigma Aldrich Corporation, CRISPR THERAPEUTICS, Intellia Therapeutics, Inc., Caribou Biosciences, Inc.
• These participants are capitalizing on unique advantages offered by the nuclease technology, they are working on.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Genome Editing Market on the basis of technology, delivery method, application, end-use, service, and region: 

Molecular Scissors/Genome Editing Technology Outlook (Revenue, USD Million, 2014 - 2025)

• (CRISPR)/Cas9
• TALENs/MegaTALs
• ZFN
• Others

Molecular Scissors/Genome Editing Delivery Method Outlook (Revenue, USD Million, 2014 - 2025)

• Ex-Vivo
• In-Vivo

Molecular Scissors/Genome Editing Application Outlook (Revenue, USD Million, 2014 - 2025)

• Cell Line Engineering
• Animal Genetic Engineering
• Plant Genetic Engineering
• Other Applications

Molecular Scissors/Genome Editing End-use Outlook (Revenue, USD Million, 2014 - 2025)

• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Contract Research Organizations

Molecular Scissors/Genome Editing Service Outlook (Revenue, USD Million, 2014 - 2025)

• Contract
• In-house

Molecular Scissors/Genome Editing Service Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Middle East and Africa (MEA)
• South Africa

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-genome-editing-market                

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Genotyping Market Analysis By Product, Technology, Application, And Segment Forecast Up To 2024

Global Genotyping Market is expected to reach USD 37.1 billion by 2024 according to a new report by Grand View Research, Inc. The increasing demand for genotyping tests to evaluate drug efficacy and safety is one of the major drivers for the genotyping market. Genotyping tests are widely used in selecting a highly responsive, patient population subset against a specific drug candidate before initiating clinical trials. The rising need for affordable genotyping services coupled with the high demand for personalized medicines is also expected to propel the market growth. 

Major pharmaceutical companies are collaborating with diagnostic manufacturers for the development of novel biomarker-based therapeutics. Significant opportunities for the growth of this market are anticipated due to the above-mentioned collaborative initiatives. 

The increasing awareness for prenatal genetic testing pertaining to early detection of chromosomal abnormalities in the high-risk population, the introduction of technological advancements, and the increasing R&D funding are the other factors accentuating the market growth over the forecast period. 

Full Research Report on Global Genotyping Market Analysis:
http://www.grandviewresearch.com/industry-analysis/genotyping-market

Further key findings from the study suggest:

• The reagents and kits segment dominated the product segment in 2015. Extensive usage of reagents for research activities and the wide applicability of the genotyping tests in disease diagnosis and validation are the factors responsible for its large share
• The reagent and kits segment is also anticipated to witness the highest growth over the forecast period. The major factors responsible for the lucrative growth of this segment are a high amount of R&D activities undertaken by research and academic institutes for the development of novel genetic biomarkers.
• In 2015, the polymerase chain reaction technology captured a significant market share owing to the higher acceptance levels by researchers and the introduction of technologically advanced and user-friendly products
• The diagnostic center was one of the largest segments with a market share of over39.0% in 2015. The rising demand for genotyping tests coupled with the high awareness for genetic disorders is a key driver for its large market share. Personalized medicine is expected to grow at a significant growth rate over the forecast period due to the increasing demand for the efficient and fast-acting therapeutics under the precision medicine category.
• North America held the largest share of thegenotyping market in 2015.The rising healthcare expenditure, established R&D infrastructure, and the increasing awareness among doctors for hereditary genetic disorders are the factors contributing to the large share.
• Asia Pacific is anticipated to be the fastest growing regional segment during the forecast period. The introduction of favorable government initiatives and programs, the geographical expansion of major players in this area, and the growing target population base are some of the factors expected to push forward the market growth.
• The key players include Affymetrix, Inc., Agilent Technologies, Inc., Genewiz, Inc., Fluidigm Corporation, GE Healthcare GmbH, Illumina, Inc., Thermo Fisher Scientific, Inc., Qiagen NV, and Roche Diagnostics
• In April 2016, Siemens Healthcare GmbH and Thermo Fisher Scientific, Inc. declared a strategic collaboration for the development of an advanced and integrated genotyping platform. This agreement aimed to introduce enhanced flexibility and customizability to their molecular testing solutions. 

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Genotyping Market on the basis of product, technology, application, and region:

Genotyping Market Product Outlook, by Revenue (USD Million, 2013 - 2024)

• Instruments
• Reagents and kits
• Services

Genotyping Market Technology Outlook, by Revenue (USD Million, 2013 - 2024)

• Polymerase Chain Reaction(PCR)
• Capillary Electrophoresis
• Mass Spectrometry
• Sequencing
• Microarray
• Other

Genotyping Market Application Outlook, by Revenue (USD Million, 2013 - 2024)

• Diagnostics
• Drug Discovery and Development
• Personalized Medicine
• Academic Research
• Agriculture
• Others

Genotyping Market Regional Outlook, by Revenue (USD Million, 2013 - 2024)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• Latin America
•  Brazil
• MEA
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-genotyping-market              

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Microtome Market Is Anticipated To Growing At A CAGR Of 4.6% During Forecast Period 2014-2025

Global Microtome Market is expected to reach USD 73.5 million by 2025, according to a new report by Grand View Research, Inc. Growing awareness about early diagnosis of chronic diseases and increasing demand for technologically advanced diagnostic equipment are some of the key factors anticipated to drive the microtome market.

According to the estimates of Laboratory Economics, in 2012, over USD 20 billion was spent on laboratory mergers between 1996 and 2011. In 2011, approximately USD 3.5 billion was spent on laboratory mergers. Increasing worldwide geriatric population, growing healthcare expenditure, and rising patient awareness regarding early disease diagnosis are some of the key factors expected to propel the tissue diagnostics market. This, in turn, is likely to boost demand for tissue slicing equipment. However, reimbursement cuts and hospital consolidation are some of the factors expected to hamper growth.

Although the U.S. ranks first in terms of per capita healthcare spending, spending on clinical laboratories is significantly lower as compared to other healthcare aspects. Moreover, overall growth in the clinical laboratory market is majorly dependent on demographic factors, technological, medical, & scientific advancements, and disease burden specific to that region. Developed economies, such as the U.S., Germany, Japan, Canada, and France, have huge R&D budgets, higher technological advancements, and more awareness regarding various health aspects as compared to developing economies. This is likely to account for majority of the share in these regions.

Growing number of histopathology laboratories, high growth potential of anatomical pathology labs in emerging economies, and rising awareness regarding digital pathological systems are some key attributes that can provide new opportunities to players. Adoption rate of histology equipment is expected to gain substantial momentum owing to growing usage of technologically advanced biomarkers in diagnosing various diseases such as cancer and other infectious diseases.

Full Research Report on Global Microtome Market Analysis:
http://www.grandviewresearch.com/industry-analysis/microtome-market

Further Key Findings From the Report Suggest:

• The global microtome market size was estimated at USD 48.6 million in 2016 and is expected to grow at a CAGR of 4.6% from 2017 to 2025
• The microtome devices segment emerged as the largest product segment in 2016
• Microtome accessories such as blades, blade holders, and clamps is anticipated to witness fastest growth over the next eight years
• The Asia Pacific region is anticipated to witness lucrative growth over the next decade. It is expected to grow at a CAGR of 9.2% over the forecast period
• Some of the key players are LLS ROWIAK LaserLabSolutions GmbH; Leica Biosystems Nussloch GmbH; Sakura.; MEDITE GmbH; SLEE medical GmbH; Boeckeler Instruments, Inc.; Nanolytik; S.M. Scientific Instruments Pvt. Ltd.; MICROS Austria Produktions-und Handelsges.m.b.H; AGD Biomedicals (P) Ltd.; Alltion; Amos Scientific Pty Ltd; and Thermo Fisher Scientific

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Microtome Market on the basis of product, technology, and region:

Product Outlook (Revenue, USD Million, 2014 - 2025)

• Microtome Devices
• Rotary Microtome
• Vibrating Microtome
• Other Microtomes
• Accessories

Technology Outlook (Revenue, USD Million, 2014 - 2025)

• Fully Automated
• Semi-Automated
• Manual

Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-microtome-market             

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com